The effect of nanoparticle polyethylene glycol surface density on ligand-directed tumor targeting studied in vivo by dual modality imaging
- PMID: 22671719
- PMCID: PMC3389615
- DOI: 10.1021/nn301630n
The effect of nanoparticle polyethylene glycol surface density on ligand-directed tumor targeting studied in vivo by dual modality imaging
Abstract
The development and application of nanoparticles as in vivo delivery vehicles for therapeutic and/or diagnostic agents has seen a drastic growth over the last decades. Novel imaging techniques allow real-time in vivo study of nanoparticle accumulation kinetics at the level of the cell and targeted tissue. Successful intravenous application of such nanocarriers requires a hydrophilic particle surface coating, of which polyethylene glycol (PEG) has become the most widely studied and applied. In the current study, the effect of nanoparticle PEG surface density on the targeting efficiency of ligand-functionalized nanoemulsions was investigated. We synthesized 100 nm nanoemulsions with a PEG surface density varying from 5 to 50 mol %. Fluorescent and paramagnetic lipids were included to allow their multimodal detection, while RGD peptides were conjugated to the PEG coating to obtain specificity for the α(v)β(3)-integrin. The development of a unique experimental imaging setup allowed us to study, in real time, nanoparticle accumulation kinetics at (sub)-cellular resolution in tumors that were grown in a window chamber model with confocal microscopy imaging, and at the macroscopic tumor level in subcutaneously grown xenografts with magnetic resonance imaging. Accumulation in the tumor occurred more rapidly for the targeted nanoemulsions than for the nontargeted versions, and the PEG surface density had a strong effect on nanoparticle targeting efficiency. Counterintuitively, yet consistent with the PEG density conformation models, the highest specificity and targeting efficiency was observed at a low PEG surface density.
Figures






Similar articles
-
Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.J Nucl Med. 2004 Oct;45(10):1776-83. J Nucl Med. 2004. PMID: 15471848
-
Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles.Int J Nanomedicine. 2012;7:5889-900. doi: 10.2147/IJN.S36847. Epub 2012 Nov 27. Int J Nanomedicine. 2012. PMID: 23226020 Free PMC article.
-
RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells.Drug Deliv Transl Res. 2015 Feb;5(1):15-26. doi: 10.1007/s13346-014-0210-2. Drug Deliv Transl Res. 2015. PMID: 25787336
-
A systematic analysis of peptide linker length and liposomal polyethylene glycol coating on cellular uptake of peptide-targeted liposomes.ACS Nano. 2013 Apr 23;7(4):2935-47. doi: 10.1021/nn305663e. Epub 2013 Mar 5. ACS Nano. 2013. PMID: 23421406
-
Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):427-43. doi: 10.1016/j.ejpb.2013.07.002. Epub 2013 Jul 17. Eur J Pharm Biopharm. 2013. PMID: 23872180 Review.
Cited by
-
A supramolecular platform for controlling and optimizing molecular architectures of siRNA targeted delivery vehicles.Sci Adv. 2020 Jul 29;6(31):eabc2148. doi: 10.1126/sciadv.abc2148. eCollection 2020 Jul. Sci Adv. 2020. PMID: 32832695 Free PMC article.
-
Self-assembling peptide-based building blocks in medical applications.Adv Drug Deliv Rev. 2017 Feb;110-111:65-79. doi: 10.1016/j.addr.2016.08.006. Epub 2016 Aug 14. Adv Drug Deliv Rev. 2017. PMID: 27535485 Free PMC article. Review.
-
Nanomedicine Penetration to Tumor: Challenges, and Advanced Strategies to Tackle This Issue.Cancers (Basel). 2022 Jun 13;14(12):2904. doi: 10.3390/cancers14122904. Cancers (Basel). 2022. PMID: 35740570 Free PMC article. Review.
-
Anticancer nanoparticulate polymer-drug conjugate.Bioeng Transl Med. 2016 Oct 28;1(3):277-296. doi: 10.1002/btm2.10033. eCollection 2016 Sep. Bioeng Transl Med. 2016. PMID: 29313017 Free PMC article. Review.
-
pH-Promoted Release of a Novel Anti-Tumour Peptide by "Stealth" Liposomes: Effect of Nanocarriers on the Drug Activity in Cis-Platinum Resistant Cancer Cells.Pharm Res. 2018 Sep 12;35(11):206. doi: 10.1007/s11095-018-2489-z. Pharm Res. 2018. PMID: 30209680
References
-
- Wagner V, Dullaart A, Bock AK, Zweck A. The Emerging Nanomedicine Landscape. Nat. Biotechnol. 2006;24:1211–1217. - PubMed
-
- Mulder WJ, Cormode DP, Hak S, Lobatto ME, Silvera S, Fayad ZA. Multimodality Nanotracers for Cardiovascular Applications. Nat. Clin. Pract. Cardiovasc. Med. 2008;5(Suppl 2):S103–S111. - PubMed
-
- Torchilin VP. Multifunctional Nanocarriers. Adv. Drug Deliv. Rev. 2006;58:1532–1555. - PubMed
-
- Ali Z, Abbasi AZ, Zhang F, Arosio P, Lascialfari A, Casula MF, Wenk A, Kreyling W, Plapper R, Seidel M, et al. Multifunctional Nanoparticles for Dual Imaging. Anal. Chem. 2011;83:2877–2882. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources